Table 3 List of pathways for cMyc dataset. List of pathways (from KEGG database) that include at least 5% of genes whose expression pattern has changed significantly upon cMyc activation
KEGG ID | Pathway Description | KEGG ID | Pathway Description |
|---|---|---|---|
path:rno00020 | Citrate cycle (TCA cycle) | path:rno00920 | Sulfur metabolism |
path:rno00051 | Fructose and mannose metabolism | path:rno01510 | Neurodegenerative Disorders |
path:rno00052 | Galactose metabolism | path:rno03010 | Ribosome |
path:rno00062 | Fatty acid biosynthesis (path 2) | path:rno03020 | RNA polymerase |
path:rno00071 | Fatty acid metabolism | path:rno03022 | Basal transcription factors |
path:rno00072 | Synthesis and degradation of ketone bodies | path:rno03030 | DNA polymerase |
path:rno00230 | Purine metabolism | path:rno04010 | MAPK signaling pathway |
path:rno00240 | Pyrimidine metabolism | path:rno04020 | Calcium signaling pathway |
path:rno00280 | Valine, leucine and isoleucine degradation | path:rno04070 | Phosphatidylinositol signaling system |
path:rno00310 | Lysine degradation | path:rno04110 | Cell cycle |
path:rno00340 | Histidine metabolism | path:rno04210 | Apoptosis |
path:rno00350 | Tyrosine metabolism | path:rno04310 | Wnt signaling pathway |
path:rno00380 | Tryptophan metabolism | path:rno04510 | Focal adhesion |
path:rno00440 | Aminophosphonate metabolism | path:rno04520 | Adherens junction |
path:rno00480 | Glutathione metabolism | path:rno04530 | Tight junction |
path:rno00510 | N-Glycan biosynthesis | path:rno04540 | Gap junction |
path:rno00561 | Glycerolipid metabolism | path:rno04620 | Toll-like receptor signaling pathway |
path:rno00564 | Glycerophospholipid metabolism | path:rno04630 | Jak-STAT signaling pathway |
path:rno00590 | Prostaglandin and leukotriene metabolism | path:rno04810 | Regulation of actin cytoskeleton |
path:rno00620 | Pyruvate metabolism | path:rno04910 | Insulin signaling pathway |
path:rno00624 | 1- and 2-Methylnaphthalene degradation | path:rno05010 | Alzheimer's disease |
path:rno00630 | Glyoxylate and dicarboxylate metabolism | path:rno05020 | Parkinson's disease |
path:rno00650 | Butanoate metabolism | path:rno05030 | Amyotrophic lateral sclerosis (ALS) |
path:rno00720 | Reductive carboxylate cycle (CO2 fixation) | path:rno05040 | Huntington's disease |
path:rno00790 | Folate biosynthesis | path:rno05060 | Prion disease |
path:rno00903 | Limonene and pinene degradation |